Lithium Phosphate Monobasic (CAS NO : 13453-80-0)

Lithium dihydrogen phosphate (CAS 13453-80-0) has emerged as a high-performance component within the API intermediates market, where high purity fine chemicals (Pharma/API purity 99% | General Industry purity 98%) are critical for stabilizing electrolytic interfaces in advanced medicinal chemistry. Phosphoric acid monolithium salt serves as a vital precursor in custom synthesis services for next-generation material science, reflecting a global sourcing shift toward specialized CDMOs that require rigorous analytical validation for battery-grade pharmaceutical precursors. Monolithium phosphate remains a preferred choice for a bulk chemical supplier focusing on the energy-efficient synthesis of cathode materials and catalysts, meeting the escalating regulatory demand for sustainable, high-purity industrial inputs (Pharma/API purity 99% | General Industry purity 98%). As globally established Lithium Phosphate Monobasic supplier, we ensure dependable supply, consistent quality, and complete regulatory documentation, including CoA and TDS across all grades. Beyond supply, we support partners through the entire product lifecycle from route scouting, process and formulation development, and analytical method development to scale-up, process optimisation, and pilot-to-commercial manufacturing. Our teams also assist with GMP-compliant quality assurance, regulatory documentation, and global supply chain and logistics coordination.